HUGE Key Statistics, Chart & Performance
The current stock price of HUGE is 0.0899 USD. In the past month the price decreased by -40.82%. In the past year, price decreased by -93.22%.
HUGE Technical Analysis
HUGE Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HUGE Forecast & Estimates
7 analysts have analysed HUGE and the average price target is 7.83 USD. This implies a price increase of 8606.04% is expected in the next year compared to the current price of 0.0899.
HUGE Ownership
About HUGE
Company Profile
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
Company Info
FSD PHARMA INC-CLASS B
55 University Ave. , Suite 1003
TORONTO ONTARIO M5X 1A4 CA
CEO: Raza Bokhari
Employees: 10
Phone: 14168548884
FSD PHARMA INC-CLASS B / HUGE FAQ
Can you describe the business of FSD PHARMA INC-CLASS B?
FSD Pharma, Inc. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. The firm operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.
What is the current price of HUGE stock?
The current stock price of HUGE is 0.0899 USD. The price decreased by -10.1% in the last trading session.
What is the dividend status of FSD PHARMA INC-CLASS B?
HUGE does not pay a dividend.
What is the ChartMill rating of FSD PHARMA INC-CLASS B stock?
HUGE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Where is FSD PHARMA INC-CLASS B (HUGE) stock traded?
HUGE stock is listed on the Nasdaq exchange.
How is the market expecting HUGE stock to perform?
7 analysts have analysed HUGE and the average price target is 7.83 USD. This implies a price increase of 8606.04% is expected in the next year compared to the current price of 0.0899.
What is FSD PHARMA INC-CLASS B worth?
FSD PHARMA INC-CLASS B (HUGE) has a market capitalization of 3.64M USD. This makes HUGE a Nano Cap stock.